The Suboxone tooth decay lawsuit is one of the most active pharmaceutical mass torts in the country right now, and thousands of people who used the drug’s sublingual film strips are filing claims in 2026. If you used Suboxone film and suffered serious dental damage, tooth loss, or decay, you may have a legitimate legal claim against its manufacturer, Indivior.
This is not a minor consumer complaint. We are talking about catastrophic dental injuries, some requiring full tooth extractions, thousands in dental bills, and documented evidence that the company knew about the risks and did not adequately warn patients.
In this guide, you will find out exactly where the lawsuit stands in 2026, what settlement amounts look like, whether you qualify, and how to file before any deadlines close.
One fact that surprises most people: the FDA issued a formal safety communication about Suboxone film and dental problems back in January 2022, and even that warning came years after patients started reporting serious tooth damage.
Suboxone Tooth Decay Lawsuit Update 2026: Where Things Stand
The Suboxone tooth decay lawsuit is progressing through the federal court system in 2026, with significant activity expected in the Northern District of Ohio where the MDL is consolidated.
As of 2026, thousands of individual plaintiffs have joined the litigation. The cases were consolidated under MDL 3092. Judge Charles Esque Fleming has been overseeing pretrial proceedings, discovery disputes, and the bellwether trial selection process.
The lawsuits allege that Indivior, the manufacturer of Suboxone sublingual film, failed to warn patients and doctors that the film’s acidic formulation could cause severe dental erosion, cavities, and tooth loss.
This is not a lawsuit about whether the drug works. It is about whether the company hid a known risk from the people who needed this medication to survive opioid addiction.
| Case Element | Details |
|---|---|
| Court | Northern District of Ohio |
| MDL Number | MDL 3092 |
| Judge | Judge Charles Esque Fleming |
| Plaintiffs | Thousands of individual claimants as of 2026 |
| Core Claim | Failure to warn about dental damage from Suboxone film |
| FDA Action | Safety communication issued January 2022 |
The trajectory in 2026 points toward either bellwether trial outcomes driving settlement negotiations or a broader resolution before mass trials begin.
Suboxone MDL Update 2026: What Is Happening in Court
The Suboxone MDL is at a pivotal stage in 2026, with bellwether cases moving toward trial and both sides engaged in heavy expert witness preparation.
MDL stands for multidistrict litigation. It is a legal tool that groups similar cases together in one court to avoid thousands of identical lawsuits clogging different federal courts across the country. Think of it like consolidating all the complaints from a defective car model into one courthouse rather than having it fought city by city.
In the Suboxone MDL, the discovery phase produced hundreds of thousands of internal Indivior documents. Plaintiffs’ attorneys argue those documents show the company was aware of the acidic pH levels in their sublingual film formulation and understood the potential for dental erosion.
| MDL Phase | Status in 2026 |
|---|---|
| MDL Consolidation | Completed, cases in Northern District of Ohio |
| Discovery | Largely completed, expert reports filed |
| Bellwether Selection | Cases selected and moving toward trial |
| Settlement Talks | Ongoing in parallel with trial preparation |
| Estimated Resolution | Late 2026 or 2027 depending on trial outcomes |
The outcome of the first bellwether trials will set the tone for what Indivior is willing to pay to resolve remaining claims.
Key Takeaway: The Suboxone MDL is deep into pretrial proceedings in 2026, with bellwether cases positioned to determine settlement values for thousands of claimants.
Who Qualifies for the Suboxone Lawsuit
You may qualify for the Suboxone lawsuit if you used Suboxone sublingual film strips and experienced significant dental damage that your dentist documented after you started the medication.
The core population of eligible claimants is people who were prescribed Suboxone film (not tablets) and suffered one or more of these outcomes: severe tooth decay, cavities, cracked or crumbling teeth, tooth loss requiring extraction, or the need for expensive dental procedures like crowns, root canals, or dentures.
You do not need to have stopped using Suboxone to file. Active users who are suffering dental injuries right now can still join the lawsuit.
Basic qualifiers at a glance:
- Prescribed Suboxone sublingual film (the strip form, not the pill)
- Experienced dental damage during or after use
- Dental damage documented by a dentist or oral health provider
- Damage was not pre-existing before Suboxone film use began
- Used the film for a meaningful duration (generally 6 months or more)
The lawsuit is not designed for people with minor sensitivity or mild whitening changes. The cases that carry the most weight involve significant structural tooth damage.
Suboxone Lawsuit Eligibility Requirements: The Full Checklist
Meeting the eligibility requirements for the Suboxone lawsuit comes down to a few specific criteria that attorneys use to evaluate whether your case is worth pursuing.
The single most important factor is documentation. If your dentist recorded your dental health before and after Suboxone film use, or at minimum has notes about the deterioration occurring during your use, that creates a strong evidentiary foundation.
| Requirement | What It Means |
|---|---|
| Drug Form | Must be Suboxone sublingual film (strips), not tablet form |
| Duration of Use | Generally 6 months or longer of film use |
| Type of Dental Damage | Severe decay, cavities, crumbling teeth, tooth loss |
| Medical Documentation | Dental records, X-rays, dentist notes |
| Timing | Damage occurred during or after film use |
| Pre-Existing Conditions | Damage cannot be entirely attributable to prior dental disease |
One thing attorneys look at carefully is the timeline. If your dental records show relatively healthy teeth before Suboxone film and dramatic deterioration within a year or two of starting it, that timeline is powerful evidence.
Pre-existing dental issues do not automatically disqualify you. They do complicate things. An attorney will assess whether the Suboxone use worsened an existing condition beyond what would have occurred naturally.
Suboxone Film Side Effects on Teeth: What the Science Says
Suboxone sublingual film causes dental damage through a combination of mechanisms that are now well-documented in both scientific literature and FDA communications.
The film is placed under the tongue, where it dissolves slowly. During that process, the strip releases an acidic compound that directly contacts tooth enamel. The acid attacks enamel over repeated daily doses in ways that are difficult to reverse.
There is a second mechanism at work too. Buprenorphine, one of the active ingredients, suppresses saliva production. Saliva is your mouth’s natural acid neutralizer. Without enough of it, the acid from the film lingers longer on tooth surfaces.
The science behind the damage:
- Suboxone film has a low (acidic) pH formulation
- Acidic environments directly erode tooth enamel
- Buprenorphine reduces saliva flow (xerostomia)
- Less saliva means less natural buffering against acid
- Daily, repeated sublingual use creates chronic acid exposure
- The FDA acknowledged this mechanism in its January 2022 safety communication
The FDA’s 2022 warning specifically stated that dental problems, “including tooth decay, cavities, oral infections, and loss of teeth have been reported” with Suboxone film and other buprenorphine-containing medications dissolved in the mouth.
That warning gave the lawsuits a massive credibility boost. The federal regulator confirmed the link.
Key Takeaway: The dental damage from Suboxone film is caused by a two-punch combination of acidic formulation and saliva reduction, both of which are now confirmed in FDA documentation.
The Suboxone Sublingual Film Lawsuit Explained
The Suboxone sublingual film lawsuit is a product liability case built on the claim that Indivior sold a defective product without adequate warnings about its dental risks.
Suboxone was approved by the FDA in 2002 as a treatment for opioid use disorder. It combines buprenorphine, a partial opioid agonist, with naloxone, an overdose reversal agent. The film formulation came later as an easier-to-use alternative to tablets.
The lawsuits do not argue the drug itself should not exist. Suboxone genuinely helps people recover from opioid addiction. The argument is narrower: the company knew or should have known about dental risks and failed to provide warnings that would have allowed patients and doctors to take protective measures.
Think of it like a power tool manufacturer selling a saw without a blade guard. The saw works fine. But the missing safety feature causes injuries that proper disclosure would have prevented.
Three main legal theories plaintiffs use:
- Failure to warn: Indivior did not adequately disclose dental risks on labels or in medication guides
- Design defect: The film’s acidic formulation itself is unreasonably dangerous
- Negligence: Indivior did not conduct sufficient post-market safety surveillance on dental outcomes
All three theories can be pursued simultaneously. Most plaintiffs’ attorneys are leading with failure to warn because the FDA’s own 2022 communication essentially validates that argument.
Indivior Lawsuit Update 2026: The Company Behind the Drug
Indivior PLC, the British pharmaceutical company that manufactures Suboxone, is facing not only the tooth decay lawsuits but carries a criminal history that significantly affects how courts and juries perceive the company.
In 2019, Indivior pleaded guilty to federal fraud charges related to deceptive marketing of Suboxone. The company agreed to pay more than $600 million in penalties in that case. A subsidiary took the criminal conviction.
That prior bad conduct matters in the civil dental damage cases. Plaintiffs’ attorneys can introduce Indivior’s history of alleged deception to argue a pattern of prioritizing profits over patient safety.
| Indivior Legal History | Details |
|---|---|
| 2019 DOJ Fraud Resolution | Paid $600 million-plus in fines and penalties |
| Nature of 2019 Case | Deceptive marketing, illegal opioid promotion |
| Current Civil Cases | Suboxone film tooth decay MDL 3092 |
| Defense Position | Warns about dental hygiene, denies liability for tooth damage |
| Company Response | Disputes causation claims, cites FDA-approved labeling |
The company argues that its updated labeling, particularly after the 2022 FDA warning, instructs patients on dental hygiene measures. Plaintiffs counter that the warning came far too late and that the damage was already done for hundreds of thousands of patients.
Key Takeaway: Indivior’s 2019 criminal fraud conviction is not just history. It directly shapes how plaintiffs present the tooth decay lawsuit as part of a broader pattern of concealment.
Is the Suboxone Tooth Decay Case a Class Action
The Suboxone tooth decay lawsuit is not a traditional class action. It is a mass tort, which is a meaningful legal distinction that affects how much money each person can receive.
In a class action, all plaintiffs share one settlement amount divided among thousands of people. In a mass tort, each person files an individual lawsuit and can receive compensation based on the specific damages they suffered.
That structure is actually better for severely injured claimants. Someone who lost six teeth gets compensated differently from someone who had two cavities treated.
Class action vs. mass tort: key differences:
| Feature | Class Action | Mass Tort (Suboxone) |
|---|---|---|
| Case Structure | One case for all | Individual cases consolidated |
| Payout Basis | Equal share of total fund | Based on individual damages |
| Injury Severity | Irrelevant to payout | Directly affects compensation |
| Opt-in Required | Sometimes | Yes, you must file individually |
| Timeline | Often faster | Can take longer but pays more |
Because the Suboxone cases are individual mass tort claims, the severity and documentation of your dental damage directly determines what you can receive. This is why detailed dental records are so valuable.
Suboxone Bellwether Trial Results: What They Mean for Your Case
Bellwether trials are test cases in mass tort litigation, and their outcomes in the Suboxone MDL are shaping settlement negotiations for every other claimant in the pool.
A bellwether trial is exactly what it sounds like. One or a few representative cases go to trial first. If the plaintiff wins big, Indivior knows it faces that risk multiplied across thousands of other cases. If the defendant wins, plaintiffs know their position is weaker.
In the Suboxone MDL, bellwether cases were selected to represent the range of plaintiff injuries, from moderate dental damage to catastrophic full-mouth tooth loss requiring implants or dentures.
The results of those early trials do several things. First, they test which legal arguments resonate with juries. Second, they reveal how experts perform under cross-examination. Third, they give both sides real data to calculate whether a global settlement makes more sense than continued litigation.
What bellwether outcomes mean for you:
- Strong plaintiff verdict: Increases settlement offers across the board
- Defense verdict: May reduce settlement offers or complicate weak cases
- Mixed results: Likely leads to tiered settlement structure based on injury severity
- No verdict yet: Means negotiations are still fluid in 2026
As of 2026, the bellwether trial outcomes are among the most closely watched events in pharmaceutical litigation. Any verdict shifts the financial calculus for Indivior significantly.
Suboxone Lawsuit Settlement Amount: What Are People Getting
No global settlement has been officially announced in the Suboxone tooth decay lawsuit as of 2026, but legal analysts and plaintiffs’ attorneys are projecting significant payouts based on the strength of the evidence and Indivior’s financial exposure.
Estimates based on similar pharmaceutical mass torts and the scale of documented injuries suggest individual settlement amounts ranging from $50,000 to $150,000 or more for severe cases. Moderate cases may settle in the $10,000 to $50,000 range.
These are projections, not guarantees. The final numbers depend heavily on bellwether trial outcomes and the size of any global settlement fund Indivior negotiates.
| Injury Severity | Estimated Settlement Range |
|---|---|
| Mild (2-3 cavities treated) | $5,000 to $15,000 |
| Moderate (crowns, root canals) | $15,000 to $50,000 |
| Severe (multiple extractions) | $50,000 to $100,000 |
| Catastrophic (full mouth tooth loss) | $100,000 to $300,000 or more |
These tiers are informed by how similar drug injury cases have resolved. They are not official Indivior offers.
The strength of your documentation, the extent of your dental damage, and whether you have a clear pre-Suboxone baseline from dental records all affect where your case falls.
Key Takeaway: Settlement amounts in the Suboxone lawsuit are not one-size-fits-all. The more severe and well-documented your dental injury, the higher your potential compensation.
Suboxone Tooth Decay Settlement Payout Tiers Explained
Settlement payout tiers in mass tort cases like the Suboxone lawsuit are structured systems that assign compensation amounts based on the type and severity of injury each claimant suffered.
When a global settlement is eventually negotiated, it will almost certainly use a tiered matrix. Every plaintiff gets placed into a tier based on specific criteria. Then attorneys and settlement administrators calculate the individual payout within that tier based on additional factors.
The factors that typically move someone to a higher tier include:
- Number of teeth affected
- Type of treatment required (extraction vs. filling vs. full denture)
- Out-of-pocket dental expenses actually paid
- Pain and suffering evidence
- Duration of Suboxone film use
- Age at time of injury (younger claimants losing teeth face longer-term consequences)
- Loss of income tied to dental injury (rare but possible)
Factors that could reduce your payout:
- Pre-existing severe dental disease before Suboxone use
- Poor dental hygiene records that predate Suboxone
- Short duration of film use (less than six months)
- Lack of formal dental documentation
- Use of Suboxone tablet form rather than film
Understanding where you fall in the tier system before settlement negotiations finalize is why getting into the litigation early matters. Your case gets evaluated as part of a pool, and earlier-filed cases often benefit from more favorable negotiating leverage.
Suboxone Lawsuit Compensation 2026: Realistic Expectations
Realistic compensation expectations for the Suboxone lawsuit in 2026 depend on three factors: how the bellwether trials go, how large the settlement fund becomes, and the individual strength of each claim.
The honest truth is that most claimants will not receive settlement money in 2026 itself. Mass tort litigation of this scale typically takes several years from MDL consolidation to actual payment distribution.
What 2026 looks like for most claimants is active case preparation, document gathering, and watching bellwether results closely.
| Stage | What It Means for Your Money |
|---|---|
| 2026: Active Litigation | No payments yet, but case building |
| Bellwether Verdicts | Sets value benchmarks for all cases |
| Global Settlement Negotiation | Could begin late 2026 or 2027 |
| Settlement Administration | Claims reviewed and assigned to tiers |
| Actual Distribution | Likely 2027 or later for most claimants |
Attorney fees in contingency-based mass tort cases typically run between 33% and 40% of any settlement. Common Benefit Fund deductions for shared litigation costs also apply. Your net recovery will be lower than the gross settlement figure.
Getting in now while the litigation is active is the move that positions you for the best possible outcome. Waiting too long risks missing filing deadlines.
Suboxone Dental Damage Lawsuit: What Counts as Evidence
Strong evidence in the Suboxone dental damage lawsuit means documented dental deterioration that correlates with your Suboxone film use period, and nothing tells that story better than your dental records.
The most powerful evidence package an attorney wants to see includes:
- Dental records from before Suboxone film use (establishes baseline)
- Dental records during and after use (shows deterioration timeline)
- Dental X-rays showing structural damage
- Treatment invoices showing costs of repairs, extractions, or prosthetics
- Prescription records confirming Suboxone film was prescribed to you
- Pharmacy records showing you filled and presumably used the prescription
Secondary evidence that strengthens your case:
- Photos of dental damage
- Testimony from your dentist
- Records of dental-related pain or emergency visits
- Any communications with doctors about dental side effects
One gap many claimants discover is that their dental history was not well documented before Suboxone. Do not panic if that is your situation. Attorneys work with imperfect records constantly. What matters is that there is some documented evidence of damage occurring during your use period.
Key Takeaway: Your dental records are the backbone of your Suboxone lawsuit claim. Start gathering them now, including records from before, during, and after your Suboxone film use period.
Suboxone Film vs Tablet Lawsuit: Does It Matter Which Form You Took
Yes, it matters significantly. The Suboxone tooth decay lawsuit specifically targets the sublingual film formulation, not the tablet or generic buprenorphine versions.
The reason is chemistry. The film strip dissolves under the tongue and releases acidic compounds directly onto tooth surfaces. The tablet form dissolves differently and does not carry the same documented dental risk profile.
The FDA’s January 2022 safety communication addressed sublingual and buccal medications containing buprenorphine specifically, citing the film-based delivery as the problematic format for dental injuries.
| Product | Lawsuit Coverage |
|---|---|
| Suboxone sublingual film strips | Yes, covered by MDL 3092 |
| Suboxone tablets | Generally not covered |
| Generic buprenorphine/naloxone film | Possibly covered, case-by-case basis |
| Subutex (buprenorphine only tablets) | Generally not covered |
| Brixia or other buccal film forms | May qualify, consult an attorney |
If you used both the film and the tablet at different points in your treatment, your eligibility may still apply for the period of film use. An attorney will evaluate your full prescription history.
If you used only tablets and have dental damage, you likely do not have a claim in this MDL. That said, separate legal theories may apply in some jurisdictions, and consulting with an attorney is the only way to confirm.
How to File a Suboxone Lawsuit Claim in 2026
Filing a Suboxone lawsuit claim in 2026 starts with connecting with a plaintiffs’ attorney who handles mass tort pharmaceutical cases, not with contacting the court directly.
This is how mass tort litigation works. Individual claimants do not file paperwork themselves with the MDL court. Instead, they retain an attorney who files on their behalf. Because these cases are taken on contingency, you pay nothing upfront. The attorney gets paid only if you win.
Step-by-step process to file in 2026:
- Contact a mass tort attorney who handles the Suboxone MDL
- Provide your basic information: Suboxone use dates, form (film or tablet), dental damage history
- Sign a contingency retainer agreement
- Gather and send dental records, prescription records, and any dental bills
- Your attorney files a short form complaint in the MDL
- Your case is officially part of the litigation pool
- You wait for the bellwether process and eventual settlement negotiations
The intake process for many firms takes less than 30 minutes over the phone or through an online form. Attorneys who specialize in this litigation know exactly what information they need and move quickly.
Having your records ready speeds things up. But if you do not have them yet, most attorneys will help you request them.
Suboxone Lawsuit Filing Deadline 2026: Do Not Wait
The Suboxone lawsuit filing deadline is governed by each state’s statute of limitations for personal injury claims, and those deadlines vary significantly from state to state.
Most states set a personal injury statute of limitations between one and three years from the date you discovered the injury or reasonably should have discovered it. The “discovery rule” is key here. It means the clock does not necessarily start the day you took Suboxone. It may start from when your dentist first documented the damage.
But do not count on that extension saving you. Courts interpret these rules differently. Waiting is genuinely risky.
| State | Personal Injury Statute of Limitations |
|---|---|
| California | 2 years from discovery |
| New York | 3 years from discovery |
| Texas | 2 years from discovery |
| Florida | 2 years from injury or discovery |
| Ohio | 2 years (MDL court state) |
| Pennsylvania | 2 years from discovery |
The MDL consolidation itself does not extend your state’s statute of limitations. Your individual claim still has a deadline tied to your state’s law.
If you used Suboxone film and noticed dental problems even two or three years ago and have not yet filed, you may be approaching or past your deadline in some states. The only way to know for certain is to speak with an attorney immediately.
Key Takeaway: Filing deadlines in the Suboxone lawsuit are state-specific and unforgiving. If you believe you have a claim, 2026 is not the year to put it off.
Suboxone Drug Maker Liability: Why Indivior Is Being Sued
Indivior is being sued because plaintiffs allege the company knew its Suboxone film formulation could damage teeth, had internal evidence supporting that conclusion, and chose not to adequately warn patients or healthcare providers.
Pharmaceutical companies have a legal duty to warn. When a drug has known risks, those risks must appear on the label, in the medication guide, and in communications to prescribers. If the company knows about a risk and does not disclose it, that is a failure-to-warn claim, which is the bedrock legal theory in this lawsuit.
The 2022 FDA safety communication essentially validated plaintiffs’ core argument. The FDA stated it was adding a warning about dental problems to all sublingual and buccal buprenorphine medications because of adverse event reports it had been receiving. Those reports existed before 2022. The question is how long Indivior had similar internal data.
Why liability arguments are strong in 2026:
- FDA’s own warning validates the causal link between the film and dental damage
- Indivior’s 2019 criminal fraud conviction establishes a corporate pattern
- Internal documents obtained during discovery reportedly show early awareness of dental risk
- Millions of patients used the film for years without any dental safety warning
- No meaningful warning existed before 2022, despite dental injury reports going back further
The defense will argue that causation is disputed, that other factors like poor dental hygiene or prior drug use caused the damage, and that the post-2022 warning fulfilled their duty going forward. These are standard pharmaceutical defense arguments. They do not eliminate liability. They limit damages in some cases.
Suboxone Withdrawal and Tooth Decay: The Hidden Connection
Suboxone withdrawal creates an additional, less-discussed pathway to dental damage that compounds the direct chemical effects of the film itself.
When patients reduce or stop Suboxone, withdrawal symptoms often include dry mouth, nausea, vomiting, and severe cravings. Each of those can worsen dental health.
Frequent vomiting introduces stomach acid into the mouth, further eroding enamel. Dry mouth during withdrawal removes saliva’s buffering protection. Patients in active withdrawal may neglect dental hygiene during a painful and disorienting period.
This creates a vicious cycle. The film damages teeth during use through acidic exposure and saliva suppression. Withdrawal compounds that damage through secondary mechanisms.
The withdrawal-dental damage connection:
- Buprenorphine suppresses saliva during active use
- Withdrawal can trigger dry mouth as a physical symptom
- Nausea and vomiting introduce stomach acid to the mouth
- Nutritional neglect during withdrawal weakens enamel from inside
- Stress-related behaviors like teeth grinding increase during withdrawal periods
This matters legally because it expands the period of Suboxone-related dental harm beyond just the active use window. Patients who used the film for two years and then went through withdrawal may have experienced dental damage across a longer total timeframe.
Documenting dental visits during the withdrawal period strengthens claims that tie the full injury picture to Suboxone film use.
Frequently Asked Questions
How much money can I get from the Suboxone tooth decay lawsuit?
Individual settlement amounts are projected to range from $5,000 for minor cases to $300,000 or more for catastrophic full-mouth tooth loss.
The exact amount depends on your injury severity, documentation quality, and where your case falls in the eventual settlement tier structure.
No official global settlement has been finalized as of 2026, so these figures are based on comparable pharmaceutical mass tort resolutions.
Is it too late to file a Suboxone tooth decay claim in 2026?
For most states, it is not too late in 2026, but deadlines are approaching for people whose dental damage was documented several years ago.
Most states give you two to three years from when you discovered the injury to file.
Speaking with an attorney now is the only way to confirm whether your state’s deadline has passed.
Do I need dental records to join the Suboxone lawsuit?
Dental records are not technically required to start the process, but they are essential to building a strong claim.
Records showing dental health before, during, and after Suboxone film use create the clearest evidence of causation.
Your attorney can help you request records from your dental providers if you do not have them already.
What is the current status of the Suboxone MDL in 2026?
The Suboxone MDL is in active litigation in the Northern District of Ohio in 2026, with bellwether cases moving toward trial.
Discovery has largely concluded, and expert witnesses have been deposed on both sides.
Settlement negotiations are running parallel to trial preparation, with outcomes of bellwether cases expected to drive resolution.
Can I sue if I used Suboxone tablets instead of the film strip?
The current MDL specifically covers Suboxone sublingual film strips, not the tablet formulation.
If you used only tablets, you likely do not have a claim in this particular litigation.
If you used both forms at different times, an attorney can evaluate whether your film use period supports a valid claim.
What You Should Do Right Now
The Suboxone tooth decay lawsuit is not slowing down in 2026. It is accelerating. Bellwether trials are moving forward, settlement discussions are heating up, and filing windows in many states are narrowing.
If you used Suboxone sublingual film strips and your teeth paid the price, this lawsuit exists specifically for you. The science backs your claim. The FDA validated the risk. And Indivior’s own legal history suggests a company that has faced accountability before and will face it again.
Pull together your dental records and prescription history. Reach out to an attorney who handles mass tort pharmaceutical cases. Do it before your state’s filing deadline closes your window for good.
